Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PANITUMUMAB Cause Hepatic function abnormal? 38 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Hepatic function abnormal have been filed in association with PANITUMUMAB (Vectibix). This represents 0.4% of all adverse event reports for PANITUMUMAB.

38
Reports of Hepatic function abnormal with PANITUMUMAB
0.4%
of all PANITUMUMAB reports
11
Deaths
14
Hospitalizations

How Dangerous Is Hepatic function abnormal From PANITUMUMAB?

Of the 38 reports, 11 (28.9%) resulted in death, 14 (36.8%) required hospitalization, and 5 (13.2%) were considered life-threatening.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PANITUMUMAB. However, 38 reports have been filed with the FAERS database.

What Other Side Effects Does PANITUMUMAB Cause?

Rash (1,392) Diarrhoea (1,123) Death (767) Dermatitis acneiform (758) Neutropenia (757) Skin toxicity (728) Neuropathy peripheral (613) Hypomagnesaemia (611) Nausea (608) Disease progression (600)

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Which PANITUMUMAB Alternatives Have Lower Hepatic function abnormal Risk?

PANITUMUMAB vs PANOBINOSTAT PANITUMUMAB vs PANTOPRAZOLE PANITUMUMAB vs PANTOPRAZOLE ANHYDROUS PANITUMUMAB vs PANTOTHENIC ACID PANITUMUMAB vs PAPAVERINE

Related Pages

PANITUMUMAB Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal PANITUMUMAB Demographics